Breaking News

What the monkeypox vaccine says about the value of investing in preparedness; the FDA's timeline on Covid vaccines for kids

 

Pharmalot Ed Silverman

STAT+: Beyond a CRISPR treatment's encouraging results, some scientists see a need for more data on risk

By Jason Mast

Adobe

Vertex, they say, has not released key information on precisely how CRISPR is impacting the DNA of patients in its trials.

Read More

Opinion: The monkeypox vaccine underscores the value of U.S. investments in preparedness

By Paul Chaplin

Adobe

The development of a monkeypox vaccine emerged from U.S. investing in medical countermeasures after the September 11 attacks in 2001.

Read More

Opinion: The FDA owes parents an explanation about why it delayed authorizing Moderna's Covid-19 vaccine for young kids

By Jorge A. Caballero

CHRIS DELMAS/AFP via Getty Images

The FDA needs to explain why it didn't authorize the use of Moderna's Covid-19 vaccine for kids under age 5 sooner than it did.

Read More

Opinion: STAT+: Why health care organizations need to invest in workforce career advancement

By Heather Brace and Vivek Sharma

Adobe

Investment in career education can be an effective approach to recruiting and retaining health care workers.

Read More

Wednesday, July 6, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments